About this trial
Multicenter, Observational, Retrospective charts review. Observational study with descriptive purpose only. Retrospective data capture in consecutive patients diagnosed with CC who attended the Oncologic Clinics from Jan 2018 to Dec 2021 (using medical records, either electronic or not), inserted in eCRF and analyzed.
Eligibility criteria
Qualifiers
Patient (or their legally acceptable representatives) must have signed and dated the Informed Consent & Privacy Form (ICF)
Age ≥18 years
Diagnosis of a cervical cancer
Locally advanced stage (not suitable for curative surgery) or recurrent or metastatic disease
Disqualifiers
Patients participating in a pharmacological clinical trial for the treatment of advanced disease
Patients who participated in a clinical trial
Patients who were administered with Pembrolizumab, Olaparib or Levantinib or medications from these class of drugs
Trial design
Treatments tested in this trial
- Not listed